Amgen Inc (AMGN)

Current ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total current assets US$ in thousands 29,030,000 26,766,000 27,206,000 28,029,000 30,332,000 48,477,000 47,380,000 44,703,000 22,186,000 24,062,000 19,322,000 18,520,000 19,385,000 24,380,000 19,099,000 21,299,000 21,144,000 22,661,000 22,895,000 18,813,000
Total current liabilities US$ in thousands 23,099,000 20,312,000 21,517,000 19,714,000 18,392,000 16,954,000 17,097,000 14,215,000 15,687,000 14,331,000 12,618,000 12,886,000 12,184,000 14,842,000 14,585,000 12,869,000 11,653,000 9,953,000 10,523,000 11,827,000
Current ratio 1.26 1.32 1.26 1.42 1.65 2.86 2.77 3.14 1.41 1.68 1.53 1.44 1.59 1.64 1.31 1.66 1.81 2.28 2.18 1.59

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $29,030,000K ÷ $23,099,000K
= 1.26

The current ratio of Amgen Inc has fluctuated over the past few years, indicating variations in the company's liquidity position. The ratio, which measures the company's ability to cover its short-term liabilities with its current assets, ranged from a low of 1.26 to a high of 3.14 during the period covered by the data.

From March 31, 2020, to June 30, 2021, the current ratio showed a generally increasing trend, reaching its peak of 2.28 on September 30, 2020. However, from December 31, 2021, to December 31, 2024, the ratio experienced a decline, dropping to as low as 1.26 on June 30, 2024.

The significant increase in the current ratio to 3.14 on March 31, 2023, suggests a noteworthy improvement in the company's liquidity position during that period. However, the subsequent decrease in the ratio indicates potential challenges in managing short-term obligations with current assets.

Overall, the current ratio of Amgen Inc has shown variability over the years, reflecting fluctuations in the company's liquidity. Further analysis of the components of current assets and liabilities may provide insights into the underlying reasons for these fluctuations and help assess the company's liquidity position more accurately.


See also:

Amgen Inc Current Ratio (Quarterly Data)